Neil Almstead
2015
In 2015, Neil Almstead earned a total compensation of $2.8M as Executive Vice President, Research, Pharmaceutical Operations & Technology at PTC Therapeutics.
Compensation breakdown
| Bonus | $2,000 |
|---|---|
| Non-Equity Incentive Plan | $168,920 |
| Option Awards | $2,225,711 |
| Salary | $410,000 |
| Other | $10,187 |
| Total | $2,816,818 |
Almstead received $2.2M in option awards, accounting for 79% of the total pay in 2015.
Almstead also received $2K in bonus, $168.9K in non-equity incentive plan, $410K in salary and $10.2K in other compensation.
Rankings
In 2015, Neil Almstead's compensation ranked 3,394th out of 13,638 executives tracked by ExecPay. In other words, Almstead earned more than 75.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,394 out of 13,638 | 75th |
Division Manufacturing | 1,232 out of 5,190 | 76th |
Major group Chemicals And Allied Products | 446 out of 1,854 | 76th |
Industry group Drugs | 356 out of 1,528 | 77th |
Industry Pharmaceutical Preparations | 283 out of 1,182 | 76th |
Source: SEC filing on April 27, 2017.
Almstead's colleagues
We found four more compensation records of executives who worked with Neil Almstead at PTC Therapeutics in 2015.